
These will be glad tidings for MS&L’s client base. MS&L serves a global health clientele which includes companies in consumer health (J&J, P&G), biotech (Amgen and Genentech), pharmaceuticals (GSK, Eli Lilly), medical devices (Phillips), and health plans and providers (Kaiser, Partners).
Some of the findings include:
Health Populi’s Hot Points: These findings should be encouraging to consumer-facing health businesses…which include every health stakeholder in the U.S. at this stage in the market. Whatever form of health financing we have in the U.S., consumers need to play a larger role in decision making, co-paying and -financing, and partnering in the production of their individual health. Whether MS&L’s MAP model will help vendors to the industry help change consumers’ less-than-ideal health behaviors — versus their inner values for health as demonstrated by this survey — remains to be seen. But in the before-and-after photos we see this time of year to promote healthy eating and fitness, I’m hopeful MS&L can convert more Americans to “afters.” That must go beyond healthy eating and exercise; it goes for the entire spectrum of health engagement. If health engagement can become a status symbol, like carrying an iPod, a Jimmy Choo doctor bag (shown at left), or Bose quiet headphones, I’ll concede that we’re in consumer-driven health mode.




Thanks to Jennifer Castenson for
yeva, digital storyteller, for engaging in
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance.